Germany - Drugs
For more information and to make a bid you will need to go to the third party website.
Details
Provided by
- Opportunity closing date
- 30 April 2025
- Opportunity publication date
- 28 March 2023
- Category
- 33600000
- Value of contract
- to be confirmed
- Your guide to exporting
Description
Kaufmännische Krankenkasse - KKH (hereinafter referred to as KKH) pursues the goal of concluding rebate contracts with all suitable pharmaceutical companies pursuant to Section 130a (8) SGB V on the active ingredient(s) within the framework of a so-called "open house procedure". All suitable and interested pharmaceutical companies or associations of pharmaceutical companies are offered the opportunity to conclude or join a rebate contract in accordance with Section 130a (8) SGB V for the above-mentioned active ingredient, subject to uniform contract conditions and a uniform access procedure. Interested pharmaceutical companies can request the participation documents as well as the contract from the contact address mentioned under l.1.
The Kaufmännische Krankenkasse - KKH (hereinafter referred to as KKH) is pursuing the goal of concluding discount agreements with all suitable pharmaceutical companies in accordance with Section 130a (8) SGB V for the following active ingredients (ATC) and, if necessary, restricting them to certain dosage forms within the framework of a so-called "open house procedure":1. Dapaglifozin ATC:A10BK01Under the specification of uniform contractual conditions as well as a uniform access procedure, all suitable and interested pharmaceutical companies or communities of pharmaceutical companies are offered the conclusion of or access to a rebate contract in accordance with Section 130a (8) SGB V for the above-mentioned active ingredient. Interested pharmaceutical companies can request the participation documents as well as the contract from the contact address mentioned under l.1. A prerequisite for the conclusion of a contract is that the interested pharmaceutical company submits the requested participation documents completely filled out and signed. A contract will be concluded with each pharmaceutical company that fulfills the participation requirements. Exclusivity is not given. The entry or the conclusion of the contract can take place at any time and under the same conditions. Individual contract negotiations are not conducted. Should the KKH carry out a tender for exclusive contracts in the form of the Open Procedure during the term of the contract for the active ingredients, the contracts concluded in the context of this publication will be terminated in accordance with the contractual provisions.
- Opportunity closing date
- 30 April 2025
- Value of contract
- to be confirmed
About the buyer
- Address
- KKH Kaufmännische Krankenkasse Karl-Wiechert-Allee 61 Hannover 30625 Germany
- Contact
- rabattvertraege@kkh.de
Bid for tender
If your company meets the requirements of the tender, go to the website where the tender is hosted and submit your bid.
This website contains links to other websites that we do not control or maintain. We are not responsible for the content of these sites. We provide these links for your convenience only, and do not necessarily endorse their content.
Before entering into a contract you need to apply for any necessary export licences, which can include applications to trade in certain goods. You should also make your own enquiries and be satisfied by the accuracy of any information supplied to you.
This opportunity has been translated from its original language. You should check if you need to apply in the original language.